Antiviral therapy in hepatitis C virus cirrhotic patients in compensated and decompensated condition
Authors:
- Angelo IacobellisAIAngelo Iacobellis
- Antonio IppolitoAIAntonio Ippolito
- Angelo AndriulliAAAngelo Andriulli
Open Access
- 1 January 2008
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 14 (42) , 6467-6472
Abstract
Antiviral therapy in hepatitis C virus cirrhotic patients in compensated and decompensated conditionKeywords
This publication has 36 references indexed in Scilit:
- Peginterferon alfa-2b and ribavirin in patients with hepatitis C virus and decompensated cirrhosis: A controlled studyJournal of Hepatology, 2007
- Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C†Hepatology, 2005
- Incidence and severity of infections according to the development of neutropenia during combined therapy with pegylated interferon-alpha2a plus ribavirin in chronic hepatitis C infectionMethods and Findings in Experimental and Clinical Pharmacology, 2005
- Epoetin alfa maintains ribavirin dose in HCV-infected patients: a prospective, double-blind, randomized controlled study1Gastroenterology, 2004
- Treatment of patients with hepatitis C virus on the waiting listLiver Transplantation, 2003
- Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantationJournal of Hepatology, 2003
- Projecting future complications of chronic hepatitis C in the United StatesLiver Transplantation, 2003
- Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis CHepatology, 2002
- Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type CJournal of Hepatology, 1997
- Inadequate erythropoietin response to anemia: definition and clinical relevanceAnnals of Hematology, 1994